SSA
NEOS

Schonfeld Strategic Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,088
Closed -$257K – 946
2017
Q3 		$257K Sell
28,088
-2,143
-7% -$16.3K 0.02% 478
2017
Q2 		$221K Buy
+30,231
New +$228K 0.02% 537

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schonfeld Strategic Advisors's NEOS Position: Q4 2017 in Review

Schonfeld Strategic Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q4 2017, closing a stake of 28,088 shares — an estimated $257K sold.

Schonfeld Strategic Advisors first reported a position in NEOS in Q2 2017 and held it in 2 quarters. The position peaked at $257K in Q3 2017. 82 funds tracked by Wall St. Rank hold NEOS as of Q4 2017.

  • Schonfeld Strategic Advisors reported no remaining Neos Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 28,088 Neos Therapeutics, Inc shares in Q4 2017, an estimated $257K.
  • Schonfeld Strategic Advisors first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Neos Therapeutics, Inc position peaked at $257K in Q3 2017.
  • 82 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.